Hepatitis C Virus (HCV) Infection Terminated Phase 3 Trials for Eltrombopag (DB06210)

Also known as: Hepatitis C (HCV) / HCV Infection / HCV Infections / HCV / Hepatits C / Hepatitis C Virus (HCV) / Hepatitis C Virus / Hepatitis C virus test

IndicationStatusPhase
DBCOND0052122 (Hepatitis C Virus (HCV) Infection)Terminated3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00678587Eltrombopag To Reduce The Need For Platelet Transfusion In Subjects With Chronic Liver Disease And Thrombocytopenia Undergoing Elective Invasive ProceduresTreatment